Long-term efficacy and safety of ustekinumab in refractory Crohn's disease patients: a multicenter retrospective experience - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Journal of Crohn's and Colitis Année : 2017

Long-term efficacy and safety of ustekinumab in refractory Crohn's disease patients: a multicenter retrospective experience

(1) , (2) , (3) , (4) , (5) , (6) , (6) , (7) , (8) , (9) , (10) , (11) , (12) , (13) , (14) , (15) , (16) , (17) , (18) , (19) , (1)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Bernard Duclos
  • Fonction : Auteur
Aurélien Amiot
  • Fonction : Auteur
Mathurin Fumery
Fichier non déposé

Dates et versions

hal-03553341 , version 1 (02-02-2022)

Identifiants

Citer

Pauline Wils, Yoram Bouhnik, Pierre Michetti, Bernard Flourie, Hédia Brixi, et al.. Long-term efficacy and safety of ustekinumab in refractory Crohn's disease patients: a multicenter retrospective experience. 12. Congress of ECCO, European Crohn's and Colitis Organisation, Feb 2017, Barcelone, Spain. ⟨hal-03553341⟩
31 Consultations
0 Téléchargements

Partager

Gmail Facebook Twitter LinkedIn More